POLITICO recently published an editorial by Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson. In the editorial, Johnson makes the case for health reform and reaffirm's PhRMA's commitment to supporting this historic effort. [More]

Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. [More]

Demand for orthopedic instrumentation products is driven by considerable rise in osteoporosis, arthritis, and joint diseases. An aging population, increasingly active lifestyles, and an expanding obese population are factors favoring demand for orthopedic implants. [More]

Reportlinker.com announces that a new market research report is available in its catalogue: Audiological Devices - Global Market Trends [More]

International prostate cancer expert Dr. Oliver Sartor of Tulane Cancer Center is the first oncologist in the United States to offer patients an experimental new treatment for late-stage prostate cancer through a multi-center clinical trial that is currently recruiting patients at 100 sites across 20 countries worldwide. [More]

The Los Angeles Times writes: "Sierra Leone is one of those nations where decades of foreign aid have failed to appreciably lift the fortunes of the people. The country is a charity case: 60% of its public spending comes from foreign governments and nonprofit organizations. [More]

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of cardiovascular and metabolic disease, today announced additional data from its ongoing Phase III trial involving its lead cholesterol management compound, lomitapide (AEGR-733), which is a microsomal triglyceride transfer protein (MTP) inhibitor small molecule drug. [More]

With unemployment at 10.2% and growing, the economic climate for many hard-working Americans is challenging, to say the least. Despite economic hard times, however, the supplement and self-care industry -- a $21 billion industry -- continues to grow at a rate of 4%-6% each year, according to GNC, the largest global specialty retailer of nutritional products including vitamin, mineral, herbal and other specialty supplements and sports nutrition, diet and energy products. [More]

Regence BlueCross BlueShield has been recognized as a Platinum-Level Start! Fit-Friendly Company by the American Heart Association's Start! movement for helping employees eat better and move more. [More]

Low-carb-low-fat-high-protein-high-fiber-Americans are food-savvy, label-conscious, calorie-aware - and still gaining weight in spite of all their good intentions. Worse still, today's children run the risk of a shorter life expectancy than their parents. [More]

As an increasing number of women from the Baby Boomer generation approach or have already reached menopause, more are seeking alternatives to prescription only treatments for menopause symptoms, and more are discovering Femnene and its line of feminine products designed specifically for a woman during and after the change of life. [More]

With a market size of US$14.5 billion in 2005 and an anticipated value of US$16.5 billion in 2006, the neurodegenerative market represents a valuable, fast-growing opportunity in the pharma/biotech industry. An increase in the number of aged people, increased life expectancy, unmet clinical needs together with advances in treatments of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease will continue to contribute to the expansion of the global market. [More]

With about 35 million people around the world suffering from Alzheimer's disease (AD) by the year 2010 and an expectation that these numbers will double every twenty years with approximately 115 million cases by 2050, pressure on healthcare systems worldwide will be intense. In a special issue of the journal Behavioural Neurology, twelve contributions from an international group of researchers discuss imaging techniques that may contribute to early diagnosis and advancements in treatment for this devastating disease. [More]

Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market. [More]

We are disappointed, but not surprised by today's vote -- an uneasiness echoed by millions of hardworking Americans as well as nearly half of the members of the U.S. House of Representatives who voted against the bill. [More]